Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
The purpose of this study is to evaluate the development of specific viral mutations in response to treatment with ABT-072.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Main Selection Criteria: A subject that has received either ABT-072 or placebo in a prior study involving ABT-072.
You may not be if
\- The investigator considers the subject unsuitable for the study for any reasons inclusive of, but not limited to, failure to comply with study procedures in a prior ABT-072 clinical study.
